Clinical Air Episode #13 Transcelerate & Industry Engagement

In September 2012, TransCelerate Biopharma launched with the aim of simplifying and accelerating the delivery of innovative medicines to patients.  What progress has really been made and what are the realistic goals for 2015? In our 2015 kick off radio show, Clinical Air Episode #13, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer talks with Dalvir Gill, PhD, CEO of Transcelerate and Andy Lee, MD, SVP, Head of Global Clinical Trial Operations at Merck. In this frank discussion, we learn: What’s working well and changes for 2015?Is Tanscelerate performing better or differently from other collaborations?How have engagements with outside organizations advanced?  Where do gaps remain?How are new areas selected and scope defined?Thoughts on implementing new ideasNew role for CROsWhat deliverables does Tanscelerate anticipate for 2015?